Genetic testing may avoid abacavir hypersensitivity reaction.
An experimental genetic test may almost eliminate the hypersensitivity reaction, which occurs in about 5% of patients starting abacavir, by identifying those at risk in advance.
James
John S
JS
D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000099227:Abacavir
D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir